#PAGE_PARAMS# #ADS_HEAD_SCRIPTS# #MICRODATA#
CS
proLékaře.cz / Journals / Journal of Czech Physicians / 2023 - 2-3

Hepatocellular carcinoma, multiple primary neoplasia, and their association with diabetes type 2

Czech version

Authors: Lucie Žabová 1;  Petr Hříbek 1;  Johana Klasová 1;  Kateřina Příhodová 2;  Petr Urbánek 1
Authors‘ workplace: Interní klinika 1. LF UK a ÚVN Praha 1;  Ústav systémového inženýrství a informatiky FES UPCE, Pardubice 2
Published in: Čas. Lék. čes. 2023; 162: 112-118
Category: Original Articles

Overview

Hepatocellular carcinoma (HCC) is the most common primary liver cancer and a frequent fatal complication of chronic liver diseases in the stage of liver cirrhosis. HCC develops at a higher rate in patients with type 2 diabetes mellitus (DM2). DM2 is associated with an increased risk of developing malignant tumors. The term multiple primary neoplasia (MPN) is used to describe the occurrence of multiple primary tumors of different organs in the same individual.

To the best of the authors knowledge, the topic of the association between HCC and MPN and DM2 has not been addressed in the Czech literature. Here we present the outcomes of retrospective statistical analysis of a cohort of patients with HCC who were dispensed at the Internal Medicine Clinic of the 1st Faculty of Medicine of the Charles University in the period 2011-2021 and the impact of DM2 and MPN on overall survival (OS). MPNs are relatively common in patients with HCC. The occurrence of MPNs in our cohort was associated with DM2 in half of the cases. Median OS in HCC patients was not significantly affected by the coincidence of DM2 and/or MPNs.

Keywords:

Cirrhosis – diabetes mellitus – hepatocellular carcinoma – multiple primary neoplasia

Sources
  1. Sung H, Ferlay J, Siegel RL, Laversanne M et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2021; 71: 209–249.
  2. McGlynn KA, Petrick JL, El-Serag HB. Epidemiology of hepatocellular carcinoma. Hepatology 2021; 73 (Suppl. 1): 4–13.
  3. Dušek L. Epidemiologie zhoubných nádorů v České republice. Masarykova univerzita, Brno, 2020. Dostupné na: www.svod.cz
  4. Llovet JM, Bru C, Bruix J. Prognosis of hepatocellular carcinoma: the BCLC staging classification. Semin Liver Dis 1999; 19: 329–338.
  5. Reig M, Forner A, Rimola J et al. BCLC strategy for prognosis prediction and treatment recommendation: the 2022 update. J Hepatol 2022; 76: 681–693.
  6. Inoue M, Iwasaki M, Otani T et al. Diabetes mellitus and the risk of cancer: results from a large-scale population-based cohort study in Japan. Arch Intern Med 2006; 166: 1871–1877.
  7. Sawamura T, Nakada H, Hazama H et al. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma. Asialoglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroenterology 1984; 87: 1217–1221.
  8. Saed L, Varse F, Baradaran HR et al. The effect of diabetes on the risk of endometrial Cancer: An updated a systematic review and meta-analysis. BMC Cancer 2019; 19: 527.
  9. Zendehdel K, Nyren O, Ostenson CG et al. Cancer incidence in patients with type 1 diabetes mellitus: a population-based cohort study in Sweden. J Natl Cancer Inst 2003; 95: 1797–1800.
  10. Andersen DK, Korc M, Petersen GM et al. Diabetes, pancreatogenic diabetes, and pancreatic cancer. Diabetes 2017; 66: 1103–1110.
  11. Nicolucci A. Epidemiological aspects of neoplasms in diabetes. Acta Diabetol 2010; 47: 87–95.
  12. La Vecchia C, Negri E, D'Avanzo B et al. Medical history and primary liver cancer. Cancer Res 1990; 50: 6274–6277.
  13. Cai C, Zeng J, Wu H et al. Association between hepatitis B virus infection and diabetes mellitus: a meta-analysis. Exp Ther Med 2015; 10: 693–698.
  14. White DL, Ratziu V, El-Serag HB. Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis. J Hepatol 2008; 49: 831–844.
  15. Curtis RE, Curtis RE, Program S. New malignancies among cancer survivors: SEER cancer registries, 1973–2000. National Cancer Institute, National Institutes of Health, Bethesda, 2006.
  16. Chopra A, Ford A, De Noronha R, Matthews S. Incidental findings on positron emission tomography/CT scans performed in the investigation of lung cancer. Br J Radiol 2012; 85: e229–e237.
  17. McLean L, Patel T. Racial and ethnic variations in the epidemiology of intrahepatic cholangiocarcinoma in the United States. Liver Int 2006; 26: 1047–1053.
  18. Weir HK, Johnson CJ, Thompson TD. The effect of multiple primary rules on population-based cancer survival. Cancer Causes Control 2013; 24: 1231–1242.
  19. Kawaciuk I. Epidemiologie karcinomu ledviny. Urologie pro praxi 2006; 6: 248–252.
  20. Fernandez-Ruiz M, Guerra-Vales JM, Castelbon-Fernandez FJ et al. Multiple primary malignancies in Spanish patients with hepatocellular carcinoma: analysis of a hospital-based tumor registry. J Gastroenterol Hepatol 2009; 24: 1424–1430.
  21. Zeng QA, Qiu J, Zou R et al. Clinical features and outcome of multiple primary malignancies involving hepatocellular carcinoma: a long-term follow-up study. BMC Cancer 2012; 12: 148.
  22. Šídlo L, Burcin B. Diabetici v Česku v období 2010–2017 se zaměřením na pacienty v péči diabetologických ambulancí. Demografie 2020; 62: 51–61.
  23. El-Serag HB, Hampel H, Javadi F. The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence. Clin Gastroenterol Hepatol 2006; 4: 369–380.
  24. Riesz T, Jako JM, Juhasz J. Secondary malignant tumors accompanied by primary hepatocellular carcinoma. Acta Hepatogastroenterol (Stuttg) 1979; 26: 364–367.
  25. Lin DY, Liaw YF, Wu CS et al. Hepatocellular carcinoma associated with second primary malignancy. Liver 1987; 7: 106–109.
  26. Lai CR, Liu HC. Hepatocellular carcinoma coexisted with second malignancy – a study of 13 cases from a consecutive 440 autopsy cases of HCC. Zhonghua Yi Xue Za Zhi (Taipei) 1990; 46: 202–207.
  27. Kanematsu M, Imaeda T, Yamawaki Y et al. Hepatocellular carcinoma with extrahepatic primary neoplasms. Gastrointest Radiol 1992; 17: 53–57.
  28. Takayasu K, Kasugai H, Ikeya S et al. A clinical and radiologic study of primary liver cancer associated with extrahepatic primary cancer. Cancer 1992; 69: 45–51.
  29. Nzeako UC, Goodman ZD, Ishak KG. Association of hepatocellular carcinoma in North American patients with extrahepatic primary malignancies. Cancer 1994; 74: 2765–2771.
  30. Di Stasi M, Sbolli G, Fornari F et al. Extrahepatic primary malignant neoplasms associated with hepatocellular carcinoma: high occurrence of B cell tumors. Oncology 1994; 51: 459–464.
  31. Onitsuka A, Hirose H, Ozeki Y et al. Clinical study on hepatocellular carcinoma with extrahepatic malignancies. Int Surg 1995; 80: 128–130.
  32. de Pangher Manzini V, Calucci F et al. Multiple primary malignant tumors in patients with hepatocellular carcinoma. A review of 29 patients. Tumori 1996; 82: 245–248.
  33. Shimada M, Takenaka K, Fujiwara Y et al. Characteristics of hepatocellular carcinoma associated with extrahepatic primary malignancies in southern Japan. Am J Gastroenterol 1996; 91: 754–758.
  34. Koide N, Hanazaki K, Fujimori Y et al. Synchronous gastric cancer associated with hepatocellular carcinoma: a study of 10 patients. Hepatogastroenterology 1999; 46: 3008–3014.
  35. Bruno G, Andreozzi P, Graf U, Santangelo G. Hepatitis C virus: a high risk factor for a second primary malignancy besides hepatocellular carcinoma. Fact or fiction? Clin Ter 1999; 150: 413–418.
  36. Wong LL, Lurie F, Takanishi DM jr. Other primary neoplasms in patients with hepatocellular cancer: prognostic implications? Hawaii Med J 2007; 66: 204–208.
Labels
Addictology Allergology and clinical immunology Angiology Audiology Clinical biochemistry Dermatology & STDs Paediatric gastroenterology Paediatric surgery Paediatric cardiology Paediatric neurology Paediatric ENT Paediatric psychiatry Paediatric rheumatology Diabetology Pharmacy Vascular surgery Pain management
ÚVODEM
EDITORIAL
Seasonal and weekly fluctuations in alcohol use in the Czech Republic
Health aspects of the behaviour of the Czech population during the COVID-19 pandemic from a public health perspective
The way to data: opinions and recommendations for the provision of health data for secondary use
The dementia-friendly community and its implications for healthcare
Physicians’ experiences of intercultural differences in communication with Ukrainian refugees during the Russian-Ukrainian armed conflict
Changes in the level of health literacy in Czechia between 2015 and 2020
Making the hospital care in the Czech Republic more effective through volunteering
Health systems in the mirror of international comparisons
Minnesota Tobacco Withdrawal Scale revision 2020, validated Czech translation
The role of interleukin 6 in the pathogenesis and therapy of Castleman disease – an immunologist's perspective
Surgical drainage, the origins and where we are today
Who was Plénies?
Purkyňova cena udělena profesoru Janu Švihovcovi
Za docentkou Jarmilou Večerkovou
Article was published in

Journal of Czech Physicians

Issue 2-3
2023 Issue 2-3
Most read in this issue
Journals
Login
Forgotten password

Enter the email address that you registered with. We will send you instructions on how to set a new password.

Login

Don‘t have an account?  Create new account

#ADS_BOTTOM_SCRIPTS#